HMGB1 can be actively or passively released into the extracellular environment, where it binds with its receptors, including receptor of advanced glycation end-product (RAGE) and toll-like receptors and regulates the development of various types of tumour 4, 5. The gene discussed is AGER; the disease is neoplasm.